Navigation Links
Isis Highlights New Clinical Data on Anti-Cancer Antisense Drugs Featured at ASCO
Date:6/1/2009

ORLANDO, Fla. and CARLSBAD, Calif., June 1 /PRNewswire-FirstCall/ -- Isis Pharmaceuticals, Inc. (Nasdaq: ISIS) announced today that Isis' collaborators presented new clinical data on drugs in Isis' partnered oncology franchise at this year's American Society of Clinical Oncology (ASCO) Annual Meeting in Orlando, Florida. In total, four presentations were featured on three drugs in Isis' oncology pipeline, including results from a Phase 2 study of OGX-011 in patients with advanced metastatic prostate cancer and Phase 1 study of OGX-427 in patients with a variety of cancers. OGX-011 and OGX-427 are antisense drugs co-discovered by Isis and OncoGenex (Nasdaq: OGXI) and Isis licensed its rights to OGX-011 to OncoGenex Pharmaceuticals, Inc. In addition, new results from a Phase 1 trial evaluating LY2181308, an antisense drug discovered by Isis and licensed to Eli Lilly and Company, in patients with cancer were also presented. Both Lilly and OncoGenex are also developing additional anti-cancer drugs in Isis' oncology franchise.

"Oncology is one of the many different therapeutic applications of our technology. Our drug discovery platform offers us virtually unlimited opportunities to expand the scope of diseases we can treat with antisense drugs," said Brett Monia, Ph.D., Vice President of Drug Discovery and Corporate Development at Isis Pharmaceuticals. "We are encouraged by the progress our partners are making with the four anti-cancer drugs in our pipeline. The positive data our partners have reported plus the exciting work from our research efforts on new anti-cancer targets have compelled us to reinvigorate our internal cancer program. We expect to have exciting new cancer drugs to enter development in the next 12 to 18 months."


'/>"/>

SOURCE Isis Pharmaceuticals, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4

Related medicine news :

1. New Fast and Precise Treatment Planning System Among Varian Medical Systems Highlights at American Brachytherapy Society 2009 Meeting
2. New survey highlights growing concern about risk of infection in cancer patients
3. New Book Highlights Human Cost of FDAs Failure to Investigate Medical Devices
4. New Survey Highlights Growing Concern About Risk of Infection in Cancer Patients and Emerging Antibiotic Resistance
5. FDAs Hydroxycut Recall Highlights the Need for Stem Cell Innovations ACTIVTox Human Liver Testing
6. Amgen Highlights Data to Be Presented at ASCO
7. Hospira Highlights Five Years of Progress and Future Opportunities at Its 2009 Annual Meeting of Shareholders
8. Dey, L.P. Highlights Perforomist(R) Inhalation Solution Data to Be Presented at the International Conference of the American Thoracic Society
9. Quality of life survey highlights need for holistic approach in elderly residential care
10. Saberi Release Highlights Case of Imprisoned Iranian AIDS Doctors
11. The Center for the Biology of Chronic Disease Highlights Anti-Cancer Activities of the Food Extracts Quercetin, EGCG, Glycyrrhizin, and Trans-Cinnamaldehyde
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/4/2009)...ric cancers, particularly Ewing sarcomas and tumor...w study published online December 4 in the Journa...y was undertaken because there is limited research...ars) for pediatric cancer patients. , Karen Wasi...d Blood Disorders Service, Children,s Healthcare o...
(Date:12/4/2009)...Hopkins publishing in the December issue of Neopl...led "Twist" may be the proverbial red flag that ca...ressive, metastatic breast cancer from other breas...ting that it is a relatively rare subgroup of stem... scientists have surmised that this subgroup of ce...
(Date:12/4/2009)...uited annually to participate in clinical trials a...tion (AHRP), and most will be compensated for thei...w payments to volunteers as compensation for time ...sks related to participating in the experiments. ,...different view of clinical trial compensation. Hig...
(Date:12/4/2009)... a phenomenon that was started by people that were...ental work in the US, Canada, and other countries....ple have found that Mexican Dental Vacation is a g... (PRWEB) December 4, 2009 -- ...ican Dental Vacation is seeing their best year eve...
(Date:12/4/2009)...mption leads to success, study finds , ,...ercise, reduced soda consumption and self-weighing...egies for adolescents, a new study shows. , Res...ht-control strategies and lifestyle habits. Sixty-... The responses were grouped into four categories: ...
Breaking Medicine News(10 mins):Health News:Potential new 'twist' in breast cancer detection 2Health News:Potential new 'twist' in breast cancer detection 3Health News:Human guinea pigs wary of high-paying medical trials 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 2Health News:Mexican Dental Vacation Sees a Rush Of New Patients: Recession A Factor 3Health News:Teens Lose More Weight Using Healthy Strategies 2
...aware of it - they might not be aware of it, but t...g you down. , New research by University of Calga...h says that regardless of their intentions, having...a complex assembly line, said Welsh If you are doi...
...N.C. The standard test for measuring blood sugar ... those on kidney hemodialysis, according to new re...enter. , Wake Forest investigators reported in K...patients and physicians. Hemodialysis, in which bl...
...s available in French . , Montreal, February 20...fight against age-related macular degeneration, or... of people. An international team, led by research...y edition of the medical journal PLoS Medicine, th...
... deficiencies in early pregnancy can cause locomot...earch from the Swedish medical university Karolins... brain development and could affect routine pregna...untreated. However, scientists are unsure about wh...
...0 LCA-Vision Inc. (Nasdaq:,LCAV), a leading provi...LasikPlus brand, announced today that its Board of...ount of $0.18 per share. The dividend will be,paya...r vision correction services,under the LasikPlus b...
...., Feb. 20 When Avaya rolls its,18-wheel Mobile B...IMSS08,next week, onboard will be a broad range of...ping healthcare organizations address critical,com...d services., As healthcare organizations increasi...
Other Medicine News:Health News:Who's slowing you down? 2Health News:Standard test for blood sugar control not accurate in diabetic dialysis patients 2Health News:AMD discovery: New hope for treatment of vision loss 2Health News:Avaya Unified Communications Solutions Help Healthcare Organizations Address Multi-Site, Mobile Workforce Challenges 2Health News:Avaya Unified Communications Solutions Help Healthcare Organizations Address Multi-Site, Mobile Workforce Challenges 3Health News:Avaya Unified Communications Solutions Help Healthcare Organizations Address Multi-Site, Mobile Workforce Challenges 4
(Date:12/4/2009)..., WASHINGTON, Dec. 4 ...t published by the Pharmaceutical Research and M... 97 new drugs and vaccines in development for HIV/... found that the 97 products in development include...ther in human clinical trials or awaiting approval...
(Date:12/4/2009)...se of imported drugs often stored in tin cans and ...USNewswire/ -- Today, the senior advocacy group Re...ortation plan encompassed in SA 2793. RetireSafe P...portation amendment is poised to open our borders,...hed, and our health to be endangered. We could so...
(Date:12/4/2009)..., Calif., Dec. 4 Suneva Medical, a...today announced the appointment of Philip Ranker a...this role, Mr. Ranker will lead all Suneva Medical...finance, accounting, IT, IR, administration and hu...s senior management team. ,, "One of my key ob...
Breaking Medicine Technology:U.S. Pharmaceutical Companies Developing 97 New Drugs and Vaccines to Fight HIV/AIDS 2RetireSafe Urges Senate to Defeat Senate Amendment 2793 -- Says Senator Dorgan's Drug Importation Plan Puts Seniors at Risk 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 2Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 3Suneva Medical Announces Corporate Developments Including Appointment of Philip Ranker as Chief Financial Officer 4IOM recommends new nutritional requirements for school meal programs 59812 1IOM recommends new nutritional requirements for school meal programs 59812 2IOM recommends new nutritional requirements for school meal programs 59812 3IOM recommends new nutritional requirements for school meal programs 59812 4Press alert for American Society of Nephrologys 42nd Annual Meeting and Scientific Exposition 59810 1Press alert for American Society of Nephrologys 42nd Annual Meeting and Scientific Exposition 59810 2GSU professor develops new method to help keep fruit vegetables and flowers fresh 10433 1GSU professor develops new method to help keep fruit vegetables and flowers fresh 10433 2
..., , , - Favorable results for secondary endpoin...May 6 Anthera Pharmaceuticals, Inc., a privately ...lammatory drugs, announced today that FRANCIS (Few...Cardiovascular Inflammation Suppression), a clinic...f varespladib when administered to patients within...
..., Two Studies at PAS Suggest Food Variety and Cogn...ng of Affected Children , , CINCINNATI, May 5 Th...ain foods places them at risk for nutritional defi...ty, according to research from Cincinnati Children...c Academic Societies meeting in Baltimore. , , Af...
Other Medicine Technology:Anthera's Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome 2Anthera's Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome 3Anthera's Varespladib Meets Primary Endpoint in Phase 2 FRANCIS Trial for the Treatment of Acute Coronary Syndrome 4Lack of Food Variety Puts Kids With Autism at Risk for Poor Nutrition 2Lack of Food Variety Puts Kids With Autism at Risk for Poor Nutrition 3
...e safety and comfort of the practitioner in mind. ...aded glass, the industry standard for radiation sh... for optical clarity, visible light transmission, ...s protecting your eyes, it also helps you look you...
Radiation Protection Goggles
QualCraft™ Euro Lite
QualCraft™ Radiation Protection Eyewear -- Metal
Medicine Products: